Aldeyra Therapeutics, Inc.
PHARMACEUTICAL FORMULATIONS AND USES THEREOF

Last updated:

Abstract:

The present invention relates to pharmaceutical compositions and unit dosage forms comprising a quinoline compound, or a pharmaceutically acceptable salt thereof, which are useful for treatment of a disease, disorder, or condition such as inflammatory diseases, respiratory diseases, organ diseases, viral infections, and sequelae and associated conditions such as acute respiratory distress syndrome.

Status:
Application
Type:

Utility

Filling date:

28 May 2021

Issue date:

23 Dec 2021